BioNTech SE (ETR:22UA)
87.60
+0.10 (0.11%)
Last updated: Apr 16, 2025
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
€406,246
Profits / Employee
€98,243
Market Cap
20.99B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Merck KGaA | 59,020 |
Siemens Healthineers AG | 72,000 |
Fresenius SE & Co. KGaA | 176,486 |
Bayer Aktiengesellschaft | 90,587 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
BioNTech SE News
- 15 days ago - Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
- 15 days ago - Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul - New York Post
- 15 days ago - Vaccine stocks fall after key FDA official resigns in protest of RFK Jr. - CNBC
- 15 days ago - Biotech stocks tumble on reports FDA's top vaccine regulator to leave - Reuters
- 18 days ago - CureVac Shares Rise on Patent Confirmation Amid BioNTech Lawsuit - Market Watch
- 18 days ago - European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps - Benzinga
- 19 days ago - CureVac up 13% as court upholds validity of patent in BioNTech spat - Seeking Alpha
- 19 days ago - CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE - Wallstreet:Online